Tag

Mind Medicine Inc.

MindMed doses first patient with MDMA-like compounds in new trial
Rowan Dunne · Sep 20, 2022
MindMed re‑establishes Nasdaq listing requirements
Rowan Dunne · Sep 14, 2022